Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 35Carcinoma, Non-Small-Cell Lung 32Colorectal Neoplasms 19Esophageal Squamous Cell Carcinoma 18Stomach Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Rectal Neoplasms 11Cholangiocarcinoma 11Head and Neck Neoplasms 10Small Cell Lung Carcinoma 9Lung Neoplasms 9Esophageal Neoplasms 9Triple Negative Breast Neoplasms 8Uterine Cervical Neoplasms 7Nasopharyngeal Carcinoma 7Urinary Bladder Neoplasms 6Recurrence 6Pancreatic Neoplasms 6Neoplasms 6Colonic Neoplasms 6Melanoma 5Hodgkin Disease 5Biliary Tract Neoplasms 4Adenocarcinoma of Lung 4Sarcoma 3Non-Muscle Invasive Bladder Neoplasms 3Neoplasm Metastasis 3NSCLC 3Locally Advanced Rectal Cancer 3Liver Neoplasms 3

Interventions

Diathermy 20Radiotherapy 11Fluorouracil 4Drug Therapy 4Cisplatin 4Radiation 3Immune Checkpoint Inhibitors 3Brachytherapy 3tislelizumab 2Surgical Procedures, Operative 2Solutions 2Immunotherapy 2Hyperthermia, Induced 2Hydrogen Peroxide 2Conization 2Capecitabine 2spartalizumab 1anlotinib 1Temozolomide 1Saline Solution 1Radiation Dose Hypofractionation 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Ifosfamide 1Hyperthermic Intraperitoneal Chemotherapy 1Gemcitabine 1Folfox protocol 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hyperthermia × tislelizumab × Clear all
NCT06249750 2024-02-08

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Zhejiang Hospital

Phase 2 Recruiting
60 enrolled

Hyperthermia

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed
18 enrolled
Gastrointestinal

Hyperthermia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡